DAVITA INC.

DVA 10-K · Q4 2025

DVA Q4 2025 request

Playground key active
Request URL /api/financials?ticker=DVA&year=2025&quarter=4
waiting 0 ms
Pick an endpoint and run the request.
curl

Income Statement

Income Statement
Metric Q4 2025 Q4 2024 YoY
Revenue From Contract With Customer Including Assessed Tax Net Of Provision For Uncollectible Accounts 3,399,232 3,119,180 +9.0%
Other Income 220,555 175,503 +25.7%
Show Business Segments breakouts
All Other Segments · Commercial Payors 613 521 +17.7%
All Other Segments · Medicaid and Managed Medicaid 0 -76 +100.0%
All Other Segments · Medicare and Medicare Advantage 182,632 158,971 +14.9%
All Other Segments · Other 33,815 14,697 +130.1%
Other Operating Segments with Intersegment · Operating Segments 214,193 169,371 +26.5%
Show — breakouts
Other Income 6,362 6,132 +3.8%
Other Income 6,362 6,132 +3.8%
Show Health Care Organization Revenue Sources breakouts
Commercial Payors 613 521 +17.7%
Medicaid and Managed Medicaid 0 -76 +100.0%
Medicare and Medicare Advantage 182,632 158,971 +14.9%
Other 40,177 20,829 +92.9%
Revenue 3,619,787 3,294,683 +9.9%
Show Business Segments breakouts
All Other Segments 564,018 425,355 +32.6%
All Other Segments · Intersegment Elimination -2,867 -4,742 +39.5%
Other Operating Segments with Intersegment · Operating Segments 566,885 430,097 +31.8%
Show — breakouts
Revenue -20,576 -18,219 -12.9%
Revenue 11,833,326 11,444,245 +3.4%
Revenue 11,772,368 11,372,498 +3.5%
Show Consolidation Items breakouts
Intersegment Elimination -23,443 -22,961 -2.1%
Operating Segments 3,643,230 3,317,644 +9.8%
Patient Care Costs 2,409,517 2,225,371 +8.3%
Show — breakouts
Patient Care Costs 2,031,164 1,925,904 +5.5%
General & Administrative 472,362 414,482 +14.0%
Show — breakouts
General & Administrative 336,174 316,209 +6.3%
Depreciation And Amortization 186,703 174,102 +7.2%
Show Business Segments breakouts
All Other Segments 23,229 16,726 +38.9%
Show — breakouts
Depreciation And Amortization 163,473 157,376 +3.9%
Income Loss From Equity Method Investments -9,865 -10,315 +4.4%
Total Costs & Expenses 3,058,717 2,729,321 +12.1%
Show Business Segments breakouts
All Other Segments · Operating Segments 529,631 331,252 +59.9%
Show — breakouts
Total Costs & Expenses 2,520,841 2,391,939 +5.4%
Operating Income 561,070 565,362 -0.8%
Show Business Segments breakouts
All Other Segments · Operating Segments 37,254 98,845 -62.3%
Show — breakouts
Operating Income 555,504 495,608 +12.1%
Show Consolidation Items breakouts
Operating Segments 592,758 594,453 -0.3%
Interest And Debt Expense -148,252 -138,721 -6.9%
Debt Prepayment Extinguishment And Modification Costs -9,028 0
Other Non-Operating Income (Expense) -21,031 -12,908 -62.9%
Income Before Taxes 382,759 413,733 -7.5%
Income Tax Expense (Benefit) 76,728 64,488 +19.0%
Net Income 331,031 349,245 -5.2%
Net Income Loss Attributable To Noncontrolling Interest -96,814 -89,916 -7.7%
Net Income 234,217 259,329 -9.7%
EPS (Basic) 3.29 3.16 +4.1%
EPS (Diluted) 3.22 3.07 +4.9%
Wtd Avg Shares (Basic) -1,541 -1,132 -36.1%
Wtd Avg Shares (Diluted) -1,557 -1,148 -35.6%
Comprehensive Income 227,594 110,867 +105.3%
Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax -1,963 9,590 -120.5%
Revenue From Contract With Customer Including Assessed Tax (Q)
Show Business Segments breakouts
All Other Segments · Commercial Payors 108,366 56,814 +90.7%
All Other Segments · Other Government Payors 241,459 199,170 +21.2%
Other Operating Segments with Intersegment · Operating Segments 349,825 255,984 +36.7%
Other Operating Segments with Intersegment · Operating Segments 2,867 4,742 -39.5%
Show — breakouts
Revenue From Contract With Customer Including Assessed Tax 3,069,983 2,881,415 +6.5%
Revenue From Contract With Customer Including Assessed Tax 3,009,025 2,809,668 +7.1%
Revenue From Contract With Customer Including Assessed Tax -8,637,393 -8,413,199 -2.7%
Revenue From Contract With Customer Including Assessed Tax 977,806 950,564 +2.9%
Revenue From Contract With Customer Including Assessed Tax -1,957,095 -1,969,316 +0.6%
Revenue From Contract With Customer Including Assessed Tax 3,911,602 3,541,619 +10.4%
Revenue From Contract With Customer Including Assessed Tax -2,479,139 -2,489,558 +0.4%
Show Health Care Organization Revenue Sources breakouts
Commercial Payors 1,086,172 1,007,378 +7.8%
Medicaid and Managed Medicaid 232,830 222,209 +4.8%
Medicare and Medicare Advantage 1,756,542 1,614,542 +8.8%
Other Government Payors 344,264 293,270 +17.4%

Balance Sheet

Balance Sheet
Metric Q4 2025 Q4 2024 YoY
Current Assets
Cash & Cash Equivalents 676,438 794,933 -14.9%
Marketable Securities (Current) 24,303 51,064 -52.4%
Accounts Receivable 2,414,690 2,146,975 +12.5%
Show Health Care Organization Revenue Sources breakouts
Medicare bad debt claims 881,191 768,536 +14.7%
Inventory 160,627 134,559 +19.4%
Other Receivables Net Current 494,414 383,166 +29.0%
Show Accounts Notes Loans And Financing Receivable By Receivable Type breakouts
Supplier rebates and non-trade receivables 222,615 132,095 +68.5%
Prepaid Expenses & Other Current Assets 156,285 122,948 +27.1%
Total Current Assets 4,058,003 3,746,072 +8.3%
Non-Current Assets
Property, Plant & Equipment 2,812,966 2,940,916 -4.4%
Show Business Segments breakouts
All Other Segments · Non Us 399,423 317,488 +25.8%
Operating Lease Right-of-Use Assets 2,397,179 2,393,558 +0.2%
Marketable Securities (Non-Current) 40,966 33,660 +21.7%
Other Non-Current Assets 246,520 261,731 -5.8%
Goodwill 7,545,095 7,375,216 +2.3%
Show Business Segments breakouts
All Other Segments 1,017,479 857,996 +18.6%
U S Dialysis 6,527,616 6,517,220 +0.2%
Show Business Acquisition breakouts
Series Of Individually Immaterial Business Acquisitions 71,684 349,069 -79.5%
Total Assets 17,480,103 17,285,268 +1.1%
Show Consolidated Entities breakouts
Variable Interest Entity Primary Beneficiary 640,481
Intangible Assets (Q)
Show Finite Lived Intangible Assets By Major Class breakouts
Service Agreements 45,025
Other Assets
Restricted Cash And Cash Equivalents 81,309 84,892 -4.2%
Income Taxes Receivable 49,937 27,535 +81.4%
Intangible Assets Net Excluding Goodwill 222,125 197,431 +12.5%
Investments In Affiliates Subsidiaries Associates And Joint Ventures 157,249 336,684 -53.3%
Show Investment Type breakouts
Equity Securities 23,763 21,732 +9.3%
Show Partner Type Of Partners Capital Account breakouts
Other Ownership Interest 133,486 99,246 +34.5%
Current Liabilities
Accounts Payable 696,148 547,200 +27.2%
Other Liabilities Current 893,024 934,145 -4.4%
Employee Related Liabilities Current 793,478 800,484 -0.9%
Operating Lease Liability Current 425,484 410,411 +3.7%
Long Term Debt And Capital Lease Obligations Current 109,201 270,867 -59.7%
Accrued Income Taxes Current 24,359 10,303 +136.4%
Total Current Liabilities 3,141,634 2,973,410 +5.7%
Non-Current Liabilities
Operating Lease Liabilities 2,175,658 2,209,655 -1.5%
Other Non-Current Liabilities 83,516 169,588 -50.8%
Deferred Tax Liabilities 756,869 665,361 +13.8%
Total Liabilities 16,321,665 15,193,917 +7.4%
Show Consolidated Entities breakouts
Variable Interest Entity Primary Beneficiary 215,650
Other Liabilities
Due To Related Party 199,940
Long Term Debt And Capital Lease Obligations 10,163,988 9,175,903 +10.8%
Stockholders' Equity
Common Stock 69 90 -23.3%
Retained Earnings -328,428 1,534,630 -121.4%
Treasury Stock Value -199,940 -1,389,072 +85.6%
Accumulated Other Comprehensive Income -122,783 -310,796 +60.5%
Total Stockholders' Equity -651,082 121,122 -637.5%
Minority Interest 277,354 274,746 +0.9%
Stockholders Equity Including Portion Attributable To Noncontrolling Interest -373,728 395,868 -194.4%
Show Equity Components breakouts
Accumulated Foreign Currency Adjustment Including Portion Attributable To Noncontrolling Interest -100,385 -302,285 +66.8%
Accumulated Gain Loss Cash Flow Hedge Including Noncontrolling Interest -22,398 -8,557 -161.8%
Accumulated Other Comprehensive Income -122,783 -310,796 +60.5%
Aoci Including Portion Attributable To Noncontrolling Interest -122,783 -310,796 +60.5%
Common Stock 69 90 -23.3%
Noncontrolling Interest 277,354 274,746 +0.9%
Parent -651,082 121,122 -637.5%
Retained Earnings -328,428 1,534,630 -121.4%
Treasury Stock Common -199,940 -1,389,072 +85.6%
Total Liabilities & Equity 17,480,103 17,285,268 +1.1%
Common Stock Par Or Stated Value Per Share 0 0 0.0%
Common Stock Shares Authorized 450,000 450,000 0.0%
Common Stock Shares Issued 68,549 90,369 -24.1%
Redeemable Noncontrolling Interest Equity Carrying Amount 1,532,166 1,695,483 -9.6%
Preferred Stock Par Or Stated Value Per Share 0 0 0.0%
Preferred Stock Shares Authorized 5,000 5,000 0.0%

Cash Flow Statement

Cash Flow Statement
Metric YTD Q4 2025 YTD Q4 2024 YoY
Operating Activities
Depreciation Amortization And Accretion Net 186,703 174,102 +7.2%
Loss On Extinguishment Of Debt 8,133 0
Stock-Based Compensation 38,394 27,396 +40.1%
Deferred Income Taxes 17,585 -4,127 +526.1%
Adjustment Income Loss From Equity Method Investments 42,781 24,739 +72.9%
Other Non-Cash Items -29,071 -10,745 -170.6%
Change in Accounts Receivable -65,944 145,877 -145.2%
Change in Inventory -20,863 -2,553 -717.2%
Increase Decrease In Other Current Receivables And Other Current Assets 29,131 -35,676 +181.7%
Increase Decrease In Other Noncurrent Assets -40,232 -54,173 +25.7%
Change in Accounts Payable 30,424 45,113 -32.6%
Increase Decrease In Employee Related Liabilities -43,321 -12,627 -243.1%
Increase Decrease In Other Current Liabilities -46,425 11,087 -518.7%
Increase Decrease In Accrued Income Taxes Payable 80,880 -36,686 +320.5%
Change in Other Liabilities 21,520 974 +2109.4%
Net Cash from Operations 540,726 547,627 -1.3%
Investing Activities
Capital Expenditures -145,430 -170,657 +14.8%
Proceeds From Sales Of Business Affiliate And Productive Assets 1,836 7,925 -76.8%
Payments To Acquire Held To Maturity Securities -563 0
Proceeds From Sale And Maturity Of Held To Maturity Securities 7,362 546 +1248.4%
Proceeds From Sale And Maturity Of Other Investments 17 8 +112.5%
Payments To Acquire Equity Method Investments -24,564 -708 -3369.5%
Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital 26 126 -79.4%
Net Cash from Investing -163,126 -247,974 +34.2%
Financing Activities
Proceeds From Issuance Of Long Term Debt 940,110 676 +138969.5%
Repayments Of Debt And Capital Lease Obligations -908,124 -77,306 -1074.7%
Payments Of Financing Costs -27,403 -4,863 -463.5%
Share Repurchases -274,479 -365,382 +24.9%
Payments Of Distributions To Affiliates -91,549 -107,806 +15.1%
Net Proceeds From Issuance Of Stock To Employees 5,707 5,249 +8.7%
Tax Withholding for Share Compensation -1,527 -6,340 +75.9%
Proceeds From Contributions From Affiliates 3,079 3,876 -20.6%
Proceeds From Minority Shareholders 3,625 0
Payments To Minority Shareholders -9,613 -13,207 +27.2%
Net Cash from Financing -414,521 -565,103 +26.6%
Other Cash Flow
Net Change in Cash -37,667 -278,819 +86.5%
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 757,747 879,825 -13.9%

Values in thousands USD. Source: SEC EDGAR 10-K filing.

This table is rendered from the same JSON returned by /api/financials.

Get API Key